On April 25, 2019, the U.S. Food and Drug Administration (“FDA”) approved new biosimilar product EticovoTM (etanercept-ykro) by...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]
Regulatory
-
-
FDA approves the second Enbrel® (etanercept) biosimilar—no etanercept biosimilar has launched in the United States to date.FDA approves...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
Coherus launches UdenycaTM, a pegfilgrastim biosimilar, in the United States. Pfizer launches Retacrit®, an epoetin alfa...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
European Medicines Agency approves first two pegfilgrastim biosimilars and another adalimumab biosimilar Pfizer launches NivestymTM,...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
FDA approves first Neulasta® (pegfilgrastim) and Procrit® (epoetin alfa) biosimilars and second Neupogen® (filgrastim biosimilar)...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
European Medicines Agency approves second trastuzumab and third insulin glargine biosimilars FDA has not approved any biosimilar...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
U.S. Food & Drug Administration and European Medicines Agency approve first trastuzumab biosimilars U.S. Food & Drug...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
European Medicines Agency newly approves two adalimumab biosimilars U.S. Food & Drug Administration approves first bevacizumab...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK] -
According to a new report by RAND Corporation, biosimilars could save $54 billion in healthcare spending on biologics over the next ten...
http://twitter.com/share?text="[TITLE]&url=[PERMALINK]